References
[1] Dorsey, E.R., & Bloem, B.R. (2018). The Parkinson Pandemic—A Call to Action. JAMA Neurology, 75(1), 9-10.
[2] Kalia, L.V., & Lang, A.E. (2015). Parkinson’s disease. The Lancet, 386(9996), 896-912.
[3] Chaudhuri, K.R., & Schapira, A.H.V. (2009). Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. The Lancet Neurology, 8(5), 464-474.
[4] Poewe, W., Seppi, K., & Tanner, C.M. (2017). Parkinson disease. Nature Reviews Disease Primers, 3(1), 1-21.
[5] Connolly, B.S., & Lang, A.E. (2014). Pharmacological treatment of Parkinson disease: a review. JAMA, 311(16), 1670-1683.
[6] Benabid, A.L., Chabardes, S., & Torres, N. (2016). Deep brain stimulation: from neurology to psychiatry? Trends in Neurosciences, 39(10), 689-696.
[7] Bronstein, J.M., Tagliati, M., & McIntyre, C. (2011). The rationale driving the evolution of deep brain stimulation to constant-current devices. Neuromodulation: Technology at the Neural Interface, 14(2), 85-88.
[8] Lozano, A.M., & Lipsman, N. (2013). Probing and regulating dysfunctional circuits using deep brain stimulation. Neuron, 77(3), 406-424.
[9] Dallapiazza, R.F., & Lee, D.J. (2019). Focused ultrasound: an emerging therapeutic modality for neurologic disease. Neurosurgical Focus, 46(2), E9.
[10] Lefaucheur, J.P., Aleman, A., & Baeken, C. (2020). Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clinical Neurophysiology, 131(2), 474-528.
[11] Woods, A.J., Antal, A., & Bikson, M. (2016). A technical guide to tDCS, and related non-invasive brain stimulation tools. Clinical Neurophysiology, 127(2), 1031-1048.
[12] Ben-Menachem, E., Revesz, D., & Simon, B.J. (2015). Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability. European Journal of Neurology, 22(9), 1260-1268.
[13] DeGiorgio, C.M., Soss, J., & Cook, I.A. (2013). Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology, 80(9), 786-791.
[14] Moher, D., Liberati, A., Tetzlaff, J., & Altman, D.G. (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine, 6(7), e1000097.
[15] Liberati, A., Altman, D.G., Tetzlaff, J., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 339, b2700.
[16] Hallett, M. (2007). Transcranial magnetic stimulation: a primer. Neuron, 55(2), 187-199.
[17] Nitsche, M.A., Cohen, L.G., Wassermann, E.M., et al. (2008). Transcranial direct current stimulation: State of the art 2008. Brain Stimulation, 1(3), 206-223.
[18] Deuschl, G., & Agid, Y. (2003). Subthalamic neurostimulation for Parkinson’s disease with early fluctuations: balancing the risks and benefits. The Lancet Neurology, 2(10), 621-628.
[19] Ben-Menachem, E. (2002). Vagus nerve stimulation, side effects, and long-term safety. Journal of Clinical Neurophysiology, 19(5), 415-418.
[20] Lefaucheur, J.P., André-Obadia, N., Antal, A., et al. (2014). Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology, 125(11), 2150-2206.
[21] Chou, Y.H., Hickey, P.T., Sundman, M., et al. (2015). Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis. JAMA Neurology, 72(4), 432-440.
[22] Nitsche, M.A., & Paulus, W. (2000). Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. The Journal of Physiology, 527(3), 633-639.
[23] BroederS., Nackaerts, E., Heremans, E., et al. (2019). Transcranial direct current stimulation in Parkinson’s disease: Neurophysiological mechanisms and behavioral effects. Neuroscience & Biobehavioral Reviews, 104, 27-39.
[24] Fregni, F., Simon, D.K., Wu, A., et al. (2005). Non-invasive brain stimulation for Parkinson’s disease: a systematic review and meta-analysis of the literature. Journal of Neurology, Neurosurgery & Psychiatry, 76(12), 1614-1623.
[25] Ben-Menachem, E. (2002). Vagus nerve stimulation, side effects, and long-term safety. Journal of Clinical Neurophysiology, 19(5), 415-418.
[26] Groves, D.A., & Brown, V.J. (2005). Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neuroscience & Biobehavioral Reviews, 29(3), 493-500.
[27] Farrand, A.Q., Helke, K.L., Gregory, R.A., et al. (2017). Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson’s disease. Brain Stimulation, 10(6), 1045-1054.
[28] DeGiorgio, C.M., Soss, J., & Cook, I.A. (2013). Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology, 80(9), 786-791.
[29] Jackson, M.J., Albequerque, L., Martinez, A., et al. (2019). Trigeminal nerve stimulation: potential therapeutic applications in Parkinson’s disease. Journal of Parkinson’s Disease, 9(3), 457-470.
[30] Beitz, J.M. (2014). Parkinson’s disease: a review. Frontiers in Bioscience, 6, 65-74.
[31] Chou, Y. H., Hickey, P. T., Sundman, M., Song, A. W., & Chen, N. K. (2015). Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson’s disease: a systematic review and meta-analysis. JAMA Neurology, 72(4), 432-440.
[32] Lefaucheur, J. P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., … & Garcia-Larrea, L. (2014). Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology, 125(11), 2150-2206.
[34] Kaski, D., Dominguez, R. O., Allum, J. H., Islam, A. F., & Bronstein, A. M. (2014). Combining physical training with transcranial direct current stimulation to improve gait in Parkinson’s disease: a pilot randomized controlled study. Clinical Rehabilitation, 28(11), 1115-1124.
[35] Brys, M., Fox, M. D., Agarwal, S., Biagioni, M., Dacpano, G., Kumar, P., … & Shukla, A. W. (2016). Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial. Neurology, 87(18), 1907-1915.
[36] Nitsche, M. A., Cohen, L. G., Wassermann, E. M., Priori, A., Lang, N., Antal, A., … & Pascual-Leone, A. (2008). Transcranial direct current stimulation: State of the art 2008. Brain Stimulation, 1(3), 206-223.
[37] Mertens, P., Nuti, C., Sindou, M., Guenot, M., Peyron, R., Garcia-Larrea, L., … & Laurent, B. (2004). Prelemniscal radiations: Stereotactic target for alleviating Parkinsonian tremor. Journal of Neurosurgery, 100(4), 685-689.
[38] Deeb, W., Giordano, J. J., Rossi, P. J., Mogilner, A. Y., Gunduz, A., Judy, J. W., … & Okun, M. S. (2016). Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: a review of emerging issues and technologies. Frontiers in Integrative Neuroscience, 10, 38.
[39] DeGiorgio, C. M., Shewmon, A., & Murray, D. (2010). Pilot study of trigeminal nerve stimulation (TNS) for epilepsy: a proof-of-concept trial. Epilepsia, 51(12), 2336-2343.
[40] Fox, M. D., & Greicius, M. (2010). Clinical applications of resting state functional connectivity. Frontiers in Systems Neuroscience, 4, 19.
[41] Quartarone, A., & Hallett, M. (2013). Emerging concepts in the physiological basis of dystonia. Movement Disorders, 28(7), 958-967.
[42] Zhang, J., & Ghods, A. J. (2020). Personalized deep brain stimulation for Parkinson’s disease. Frontiers in Neuroscience, 14, 612.
[43] Fisher, R., Salanova, V., Witt, T., Worth, R., Henry, T., Gross, R., … & VNS Therapy for Drug-Resistant Partial Epilepsy Study Group. (2010). Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia, 51(5), 899-908.
[44] Lozano, A. M., & Lipsman, N. (2013). Probing and regulating dysfunctional circuits using deep brain stimulation. Neuron, 77(3), 406-424.
[45] Olanow, C. W., Stern, M. B., &Sethi, K. (2009). The scientific and clinical basis for the treatment of Parkinson disease. Neurology, 72(21_suppl_4), S1-S136.